I'm beginning to agree with Chris's viewpoint, which would explain the lack of communication about specifics, but still making a point that it is "on track." Nothing is coming out on Lympro until the study extension is complete. Until then, speculate all you want, but nobody here knows for sure. I think Chris's theory makes a lot of sense when you look at everything that's been said (and not said) recently.